Home » Science » Recent Articles:

The HIV Vaccine and Science by Press Release

October 13, 2009 Research No Comments

By Jacob Goldstein

The HIV Vaccine and Science by Press ReleaseA closer look at the HIV vaccine study results announced recently suggests the vaccine may be less impressive than originally suggested, the WSJ reports.

Researchers said last month that the vaccine lowered the risk of infection by about 31% — a “modest benefit,” they said, but one that was statistically significant, suggesting the finding was not a fluke. Another slice of the data that was … Continue Reading

Partner links

Advertising

Drugs

South Korean FDA Probes Roche for Aiding Tamiflu Stockpiling

November 8, 2009

By Shirley S. Wang Should companies be allowed to buy large quantities of medicine like Tamiflu to have on hand in case their employees develop the H1N1 flu virus? Not according to the law in South Korea, where it’s illegal for non-medical professionals to purchase big lots of drugs. Punishment is up to five years [...]

Boosting Medical Students’ Training in Drug Abuse

November 7, 2009

By Shirley S. Wang There’s lot of action these days aimed at curbing the abuse of prescription drugs. The FDA is working on a plan to make it harder for people to get access to unauthorized prescription painkillers, pain specialists have come out with guidelines to help doctors manage pain-drug-abusing patients and drug companies have [...]

What Will Pfizer’s R&D Look Like a Year from Now?

October 21, 2009

By Jonathan D. Rockoff Pfizer’s huge R&D shop is even bigger now that the company has swallowed Wyeth. To get a sense of the changes that could be in store, the Health Blog spoke today with the company’s two top R&D execs — Martin Mackay, a Pfizer veteran who will lead small-molecule work, and Mikael [...]

See Your Doctor: The Dawn of Consumer Drug Ads

October 13, 2009

By Jacob Goldstein For a look back at a key breakthrough in the history of the pharmaceutical industry, we turn now to Joe Davis, a retired ad guy who lives in Vermont. Back in the mid-1980s, Davis came up with an idea: Run a TV ad for Seldane, the allergy medicine, but don’t say the [...]

Why Other Drugmakers Want to Be More Like J&J

October 12, 2009

By Jacob Goldstein Johnson & Johnson’s third-quarter earnings, out today, provide the latest reminder of why other drugmakers want to be more like J&J. In a nutshell: It’s a tough time to be in the prescription drug business, what with stiff competition from generics manufacturers and payers pushing for lower costs on branded drugs. So [...]

Related Links

Research

What Will Pfizer’s R&D Look Like a Year from Now?

October 21, 2009

By Jonathan D. Rockoff Pfizer’s huge R&D shop is even bigger now that the company has swallowed Wyeth. To get a sense of the changes that could be in store, the Health Blog spoke today with the company’s two top R&D execs — Martin Mackay, a Pfizer veteran who will lead small-molecule work, and Mikael [...]

Are Mammograms and PSA Tests Overrated?

October 21, 2009

By Jacob Goldstein Catch cancers early and treat them before they become deadly. That’s the idea behind cancer screening, and that’s clearly how it works with pap smears for cervical cancer and colonoscopy for colon cancer. But in some cases screening can lead to aggressive treatment of slow-growing tumors that would never have caused a [...]

The Problem With Ranking Countries’ Health-Care Systems

October 20, 2009

By Jacob Goldstein The oft-cited WHO ranking that said the U.S. has the 37th best health-care system in the world is dated and had problems even when it was new, WSJ stats maven Carl Bialik writes in his column today. The ranking was published in 2000, and came up against a major problem: Good data [...]